Introduction:
The pharmaceutical industry in the United States is one of the largest in the world, with a significant focus on the production of generic Active Pharmaceutical Ingredients (APIs). In recent years, the demand for generic APIs has been on the rise due to factors such as cost-effectiveness and increased access to healthcare. According to industry reports, the global market for generic APIs is expected to reach $200 billion by 2024. In this report, we will highlight the top 10 generic API manufacturers in the USA based on their production volume, market share, and exports.
Top 10 Generic Active Pharmaceutical Ingredient (API) Manufacturers in USA:
1. Teva Pharmaceutical Industries Ltd.
Teva is one of the largest generic API manufacturers in the world, with a significant presence in the USA. The company’s production volume exceeds 80,000 metric tons per year, making it a key player in the market.
2. Mylan N.V.
Mylan is another major player in the generic API manufacturing industry, with a strong foothold in the US market. The company’s market share in the USA is estimated to be around 15%, making it one of the top manufacturers in the country.
3. Sandoz International GmbH
Sandoz, a subsidiary of Novartis, is known for its high-quality generic APIs. The company has a production volume of over 60,000 metric tons per year and a significant market share in the USA.
4. Lupin Limited
Lupin is a leading Indian pharmaceutical company with a strong presence in the US market. The company’s exports of generic APIs to the USA account for a significant portion of its revenue.
5. Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s is a well-known name in the generic API manufacturing industry, with a production volume of over 50,000 metric tons per year. The company’s strong focus on research and development has helped it maintain a competitive edge in the market.
6. Aurobindo Pharma Ltd.
Aurobindo Pharma is a key player in the generic API manufacturing industry, with a market share of around 10% in the USA. The company’s exports of generic APIs to the USA have been growing steadily in recent years.
7. Sun Pharmaceutical Industries Ltd.
Sun Pharma is a leading Indian pharmaceutical company with a strong presence in the US market. The company’s production volume exceeds 40,000 metric tons per year, making it one of the top manufacturers in the country.
8. Cipla Limited
Cipla is a renowned name in the generic API manufacturing industry, with a production volume of over 30,000 metric tons per year. The company’s focus on innovation and quality has helped it maintain a strong position in the market.
9. Hikma Pharmaceuticals PLC
Hikma is a global pharmaceutical company with a significant presence in the USA. The company’s exports of generic APIs to the USA have been increasing steadily, contributing to its revenue growth.
10. Endo International plc
Endo is a key player in the generic API manufacturing industry, with a production volume of over 20,000 metric tons per year. The company’s focus on expanding its product portfolio and market presence has helped it stay competitive in the market.
Insights:
The generic API manufacturing industry in the USA is expected to continue growing in the coming years, driven by factors such as the increasing demand for affordable healthcare solutions and the rising prevalence of chronic diseases. According to industry reports, the market for generic APIs in the USA is projected to reach $50 billion by 2025. Companies that focus on innovation, quality, and expanding their global presence are likely to emerge as key players in the market. Additionally, the ongoing trend of consolidation in the industry is expected to create new opportunities for companies to expand their market share and reach new customers.
Related Analysis: View Previous Industry Report
